The £13m drug discovery partnership between Oxford University, Oxford Sciences Innovation and Evotec supported 12 new projects in first year of operation.Read More
7 high quality work packages already launched from this University-Industry collaborationRead More
LAB282, the drug discovery partnership for Oxford University, has made its second round of awards to support promising life sciences ideas with market potential emerging from the University.
Out of a potential seven candidates, LAB282 decided to support five with awards ranging into six-figure sums.Read More
Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards, backing projects targeting cardiovascular and infectious diseases.Read More
Oxford University, Oxford University Innovation, Oxford Sciences Innovation and Evotec announce a new partnership to advance the development of next-generation medicines arising from Oxford research.Read More